188 related articles for article (PubMed ID: 3118263)
1. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
Marttinen A; Pasternack A; Koivula T
Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
[TBL] [Abstract][Full Text] [Related]
2. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in uraemia. An insulin receptor or an intracellular defect?
Schmitz O; Hasling C; Hjøllund E; Hansen HE; Posborg Petersen V; Beck-Nielsen H
Proc Eur Dial Transplant Assoc; 1983; 20():686-91. PubMed ID: 6657689
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor of erythrocytes and glucose metabolism in uremic children.
Namikawa T; Namikawa T; Fujimoto S; Furuse A; Hattori S; Matsuda I; Nakahara C; Ito H
Horm Metab Res; 1983 Apr; 15(4):161-6. PubMed ID: 6345310
[No Abstract] [Full Text] [Related]
5. Decreased erythrocyte insulin receptor binding in diabetic man with chronic renal failure.
Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
Horm Metab Res; 1980 Aug; 12(8):414-5. PubMed ID: 6997168
[No Abstract] [Full Text] [Related]
6. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia.
Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M
J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603
[TBL] [Abstract][Full Text] [Related]
7. Transport of L-arginine and the nitric oxide inhibitor NG-monomethyl-L-arginine in human erythrocytes in chronic renal failure.
Mendes Ribeiro AC; Hanssen H; Kiessling K; Roberts NB; Mann GE; Ellory JC
Clin Sci (Lond); 1997 Jul; 93(1):57-64. PubMed ID: 9279204
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
9. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte transport of middle molecular substances.
Gajdos M; Spustová V; Geryková M; Dzúrik R
Proc Eur Dial Transplant Assoc; 1981; 18():183-7. PubMed ID: 7329966
[TBL] [Abstract][Full Text] [Related]
11. Effect of haemodialysis on insulin requirements in uraemic diabetic patients. Studies with the artificial beta-cell.
Schmitz O
Proc Eur Dial Transplant Assoc; 1983; 19():769-72. PubMed ID: 6348766
[TBL] [Abstract][Full Text] [Related]
12. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
13. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Rat erythrocyte insulin receptors: radioreceptor assay and characterization.
Ogunwole JO; Nerurkar SG; Hollis VW
J Natl Med Assoc; 1985 Feb; 77(2):119-28. PubMed ID: 3981646
[TBL] [Abstract][Full Text] [Related]
16. The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients.
Cohen G; Raupachova J; Wimmer T; Deicher R; Hörl WH
Nephrol Dial Transplant; 2008 Aug; 23(8):2512-9. PubMed ID: 18319358
[TBL] [Abstract][Full Text] [Related]
17. [Erythrocyte insulin receptors in the ontogeny of chickens].
Leĭbush BN; Kolychev AP; Bondareva VM
Ontogenez; 1984; 15(3):290-6. PubMed ID: 6377164
[TBL] [Abstract][Full Text] [Related]
18. Plasma inhibitors of the erythrocyte hexose monophosphate shunt in uraemia.
Zingraff J; Kamoun P; Lebreton P; Drüeke T; Man NK; Jungers P
Proc Eur Dial Transplant Assoc; 1979; 16():475-80. PubMed ID: 548990
[TBL] [Abstract][Full Text] [Related]
19. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia.
Rocić B; Breyer D; Granić M; Milutinović S
Horm Metab Res; 1991 Oct; 23(10):490-4. PubMed ID: 1761280
[TBL] [Abstract][Full Text] [Related]
20. Insulin binding to circulating monocytes and erythrocytes in patients with non-insulin-dependent diabetes in the young.
Naidoo C; Jialal I; Dunn RD; Govender T; Joubert SM
Diabetes Res; 1987 Jan; 4(1):35-8. PubMed ID: 3552365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
